CN111107861A - 包含昌化鹅耳枥叶提取物的防止脱发或毛发生长促进用组合物 - Google Patents
包含昌化鹅耳枥叶提取物的防止脱发或毛发生长促进用组合物 Download PDFInfo
- Publication number
- CN111107861A CN111107861A CN201880061001.3A CN201880061001A CN111107861A CN 111107861 A CN111107861 A CN 111107861A CN 201880061001 A CN201880061001 A CN 201880061001A CN 111107861 A CN111107861 A CN 111107861A
- Authority
- CN
- China
- Prior art keywords
- hair
- extract
- carpinus
- preventing
- leaves
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000726768 Carpinus Species 0.000 title claims abstract description 59
- 239000000284 extract Substances 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 230000003779 hair growth Effects 0.000 title claims abstract description 36
- 230000001737 promoting effect Effects 0.000 title claims abstract description 24
- 201000004384 Alopecia Diseases 0.000 title claims description 25
- 231100000360 alopecia Toxicity 0.000 title claims description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 19
- 230000003658 preventing hair loss Effects 0.000 claims abstract description 15
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 10
- 241001279241 Laxus Species 0.000 claims abstract description 5
- 210000004209 hair Anatomy 0.000 claims description 97
- 239000006071 cream Substances 0.000 claims description 19
- 239000004480 active ingredient Substances 0.000 claims description 13
- 239000006210 lotion Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 230000001256 tonic effect Effects 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 9
- -1 patches Substances 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- 235000013361 beverage Nutrition 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 235000013402 health food Nutrition 0.000 claims description 7
- 239000002674 ointment Substances 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 4
- 241000195940 Bryophyta Species 0.000 claims description 3
- 239000004909 Moisturizer Substances 0.000 claims description 3
- 239000008266 hair spray Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 230000001333 moisturizer Effects 0.000 claims description 3
- 235000011929 mousse Nutrition 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000002453 shampoo Substances 0.000 claims description 3
- 239000007844 bleaching agent Substances 0.000 claims description 2
- 239000000118 hair dye Substances 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000000865 liniment Substances 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 description 28
- 210000004027 cell Anatomy 0.000 description 25
- 210000003780 hair follicle Anatomy 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 13
- 230000002500 effect on skin Effects 0.000 description 13
- 229960003632 minoxidil Drugs 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 230000003698 anagen phase Effects 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 10
- 230000035755 proliferation Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 9
- 238000000605 extraction Methods 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 230000003676 hair loss Effects 0.000 description 7
- 208000024963 hair loss Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 230000003778 catagen phase Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 230000003797 telogen phase Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- 229960004063 propylene glycol Drugs 0.000 description 4
- 229960005322 streptomycin Drugs 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 229960004039 finasteride Drugs 0.000 description 3
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000012669 liquid formulation Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 210000003135 vibrissae Anatomy 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- GVSGSHGXUXLQNS-UHFFFAOYSA-N 3-bromo-4,5-dihydroxybenzaldehyde Chemical compound OC1=CC(C=O)=CC(Br)=C1O GVSGSHGXUXLQNS-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000995831 Carpinus tschonoskii Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 108010022394 Threonine synthase Proteins 0.000 description 2
- 102000005497 Thymidylate Synthase Human genes 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 201000002996 androgenic alopecia Diseases 0.000 description 2
- 230000000340 anti-metabolite Effects 0.000 description 2
- 229940030600 antihypertensive agent Drugs 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229940100197 antimetabolite Drugs 0.000 description 2
- 239000002256 antimetabolite Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- NWNOWCGAHDFNFJ-RUCXOUQFSA-N (2s)-2,5-bis(azanyl)-5-oxidanylidene-pentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(N)=O.OC(=O)[C@@H](N)CCC(N)=O NWNOWCGAHDFNFJ-RUCXOUQFSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- XGSXUSCKTLWSLU-UHFFFAOYSA-N 3-[dimethyl(trimethylsilyloxy)silyl]propan-1-ol Chemical compound C[Si](C)(C)O[Si](C)(C)CCCO XGSXUSCKTLWSLU-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- GSSWFBLVISCYBP-UHFFFAOYSA-N 3-chloropropyl-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)CCCCl GSSWFBLVISCYBP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ZGMLACURZVGTPK-UHFFFAOYSA-N 5-fluoranyl-1h-pyrimidine-2,4-dione Chemical compound OC1=NC=C(F)C(O)=N1.FC1=CNC(=O)NC1=O ZGMLACURZVGTPK-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- IYRBECYZGYSDIP-UHFFFAOYSA-N COCCC[SiH]1O[Si](O[SiH2]O[SiH2]O1)(CCCCCCC)C Chemical compound COCCC[SiH]1O[Si](O[SiH2]O[SiH2]O1)(CCCCCCC)C IYRBECYZGYSDIP-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000012594 Earle’s Balanced Salt Solution Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001098499 Lanceolata Species 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000012754 barrier agent Substances 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- AMNQQNTZDFYVGH-UHFFFAOYSA-N dimethyl-phenyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)C1=CC=CC=C1 AMNQQNTZDFYVGH-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 208000002854 epidermolysis bullosa simplex superficialis Diseases 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000031774 hair cycle Effects 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000003693 proliferative and anti-apoptotic effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000000551 statistical hypothesis test Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及包含昌化鹅耳枥叶提取物的防止脱发或毛发生长促进用药学组合物。包含昌化鹅耳枥叶提取物的组合物被认定为具有抑制及预防脱发且促进毛发生长的功效，因此可在药学、化妆品及美容等领域中以多种方式应用。
Description
技术领域
本发明涉及包含从昌化鹅耳枥叶提取的成分的防止脱发或毛发生长促进用组合物。
背景技术
人体的毛发在“毛囊”中形成，其数量约为10万～15万根。毛囊中具有毛乳头，在此部位中分布有小血管，用于供给毛发生长中所需的营养成分，在毛乳头上的旁边具有皮脂腺，用于供给使毛发润泽的油脂。毛囊(hair follicle)由多种不同的皮膜细胞(epithelial cells)及毛乳头细胞(dermal papilla cells，DPCs)形成。毛乳头细胞为位于毛囊的基底部的间充质由来成纤维细胞(mesenchymally-derived fibroblasts)，对毛发生长起到重要的作用。尤其，据报道，米诺地尔(minoxidil)对毛乳头细胞具有增殖及抗细胞凋亡的效果。类似地，其他报告书中提出可通过毛乳头细胞的增殖促进毛发生。毛发分别具有不同的周期，经过生长期(anagen)、退化期(catagen)、休止期(telogen)生长并脱落。这种周期经过3～6年反复进行，正常情况下每日平均脱落50～100根毛发。通常，所谓的脱发症是指在这种周期中，生长期毛发的比率减少，而退化期或休止期毛发增多，从而导致所脱落的毛发的数量非正常地增加。
抗癌化疗的副作用包括白细胞减少、呕吐、腹泻及脱发，其中众所周知，抗癌化疗所致的脱发(chemotherapy induced alopecia)约发生65％(Trueb RM，2010)，并且在因抗癌化疗所致脱发的药物中，5-氟尿嘧啶(5-fluorouracil)作为一种抗代谢物(antimetabolite)，其通过抑制胸苷酸合酶(thymidylate synthase)来诱导DNA合成抑制及细胞凋亡(Longley DB et al.,2003)。
像这样，尽管一直以来进行着有关脱发的诸多研究，但对于根本性的有关脱发的机制尚不清楚。并且，尽管一直以来还致力于脱发的治疗，但至今为止，美国食品药品管理局(FDA，Food and Drug Administration)(U.S.A)仅认可两种用于治疗脱发的药物(菲那雄胺(finasteride)及米诺地尔(minoxidil))。菲那雄胺作为5α-还原酶(5α-reductase)，一直以来用于促进男性的雄激素性脱发症(androgenetic alopecia)中的毛发生长。米诺地尔作为抗高血压剂(anti-hypertensive agent)，可通过ATP-敏感性K+-通道开放来促进毛发生长。然而，因无法预测的效果及副作用，药物的效果是有限性和暂时性的。因此，需要可预防脱发并促进毛发生长的疗效更好的新治疗药物。对于至今为止被公知为具有防止脱发且促进毛发生长效果的米诺地尔(minoxidil)或粘多糖生长素(trichosaccharide)等制剂而言，正在出现缺乏显著疗效及人体稳定性、引发皮肤刺激等副作用，因此当前实际情况为，急需开发一种确保稳定性及疗效的组合物。
昌化鹅耳枥(Carpinus tschonoskii Maxim.var.tschonoskii)是桦木科鹅耳枥属乔木。据报道，昌化鹅耳枥的抗炎及神经保护效果优秀(Koo JE，et al.，2012；Kim MK，etal.，2010)，有关昌化鹅耳枥提取物的现有发明包括包含昌化鹅耳枥叶提取物的皮肤皱纹改善用化妆品组合物(授权号10-0866784)及包含昌化鹅耳枥叶提取物的皮肤美白改善用化妆品组合物(授权号10-0967073)等。但实际情况为，几乎没有有关昌化鹅耳枥的生发及毛发生长功效的研究报告。
为此，本发明人在寻找几乎无毒性且呈现出防止脱发及促进毛发生长效果的天然物质的过程中，确认到昌化鹅耳枥叶提取物的防止脱发及促进毛发生长的效果，从而完成了本发明。
发明内容
技术问题
本发明的目的在于，提供包含昌化鹅耳枥叶提取物作为有效成分的用于防止脱发的药学组合物。
并且，本发明的目的在于，提供包含昌化鹅耳枥叶提取物作为有效成分的用于促进毛发生长的化妆品组合物。
并且，本发明的目的在于，提供包含昌化鹅耳枥叶提取物作为有效成分的用于防止脱发或促进毛发生长的保健食品。
解决问题的方案
本发明提供包含昌化鹅耳枥叶提取物作为有效成分的用于防止脱发的药学组合物。
本发明中所定义的提取物包括可溶于包括纯化水在内的水、碳原子数为1至4的低级醇或它们的混合溶剂，选自己烷、丁二醇、丙二醇、甘油、乙酸乙酯、醚、氯仿的溶剂，优选为水或甲醇的混合溶剂的提取物。
所谓的昌化鹅耳枥叶提取物，只要是从昌化鹅耳枥叶中通过提取有效成分而获得的，就不做特别限制将它们全部包括在内。例如，可以是将昌化鹅耳枥叶放入水或有机溶剂中并通过静置、搅拌、加压或加热等手段洗脱有效成分而获得的结果物。并且，包括通过对以如上所述的方式获得的液相提取物进行冷冻干燥而获得的冷冻干燥物。
并且，还包括通过粉碎上述冷冻干燥物而获得的粉末。除此之外，只要是通过本技术领域的普通技术人员可用于提取有效成分的手段来提取的，就包括通过任何手段提取的所有提取物，还将提取后经过冷冻干燥等加工的提取物也均包括在内。另外，包括通过加热或常温提取法等从以往传下来的方法或中医书籍或教科书中所记载的常规提取法提取的提取物。
并且，包括通过Stass Otto提取法或各种柱色谱法等获得的部分提取物，上述方法为用于分离特定活性化合物的特殊提取方法。
上述昌化鹅耳枥叶提取物可以不受限制地使用采集的或商购的，作为一例，可以包括将采集之后用水清洗来去除异物后干燥并粉末化来使用。
上述昌化鹅耳枥叶提取物可通过超声波提取法、过滤法及回流提取法等本技术领域的常规提取方法来获得。
优选地，可以是将昌化鹅耳枥叶试样溶解在乙醇中的提取物。
本说明书中“脱发”意味着毛发从头皮脱落的现象或毛发变稀少或变细的状态，所谓“防止脱发”意味着预防且防止如上所述的脱发现象，所谓“促进毛发生长”意味着不仅促进新的毛发的生成，还使以往毛发健康生长。
通常，“毛发生长”在生长期中形成，通过从休止期向生长期的诱导及从生长期向退行期的延迟来进行促进。毛发周期可分为周知的生长期、退行期及休止期的3个主要步骤。在生长期中，与细胞的快速增殖一同，通过向皮肤内深处生长来完成毛囊毛发的形成。其次的现象为退行期，上述退行期为细胞分裂的中断脱颖而出的过渡期，在此过程中毛囊逐渐退化，并且毛发生长中断。在作为其次的现象的休止期中，退化毛囊包含具有稠密地充满的毛乳头(dermal papilla)细胞的胚芽(germ)。在休止期中新的生长期现象的开始通过从上述胚芽的快速细胞增殖、毛乳头的膨胀及基底膜要素的合成来进行诱导。
因此，需要生长期的促进或延长来防止毛发的损失，即，引起防止脱发或毛发的再生长，即，需要促进毛发生长，本发明的组合物包含使已存在的毛发不再脱落的效果、使已存在毛发改善成变粗等的效果及生长新的毛发的效果中的一种或以上。毛乳头细胞(dermal papilla cell)作为位于毛囊的基底的中胚层由来成纤维细胞，被认为通过与毛囊的毛基质细胞的相互作用，在毛发的生长中起到重要的作用(Jahoda CA，et al.，1984；Oliver RF，et al.，1986)。并且，已证明作为2型5α-还原酶(Type 2 5α-reductase)抑制剂的菲那雄胺可通过减少脱发患者的DHT来改善脱发(Van Neste et al.，2000)，这种事实表明5α-还原酶是用于脱发治疗的重要靶点(target)。因此可知，由于本发明的组合物抑制5α-还原酶并激活毛乳头细胞，因而可以防止脱发并诱导毛发生长。
优选地，上述昌化鹅耳枥叶提取物的浓度为0.001μg/ml至10μg/ml，但不限于此。由于本发明的昌化鹅耳枥叶提取物是从天然物质中提取的，因而几乎无毒性。
在药学组合物中，相对于全部组合物的总重量，可包含0.01重量百分比至70重量百分比的上述昌化鹅耳枥叶提取物。
本发明的药学组合物可以为口服或非口服的各种剂型。在制剂化的情况下，利用通常使用的填充剂、增量剂、粘合剂、润湿剂、崩解剂、表面活性剂等的稀释剂或赋形剂来进行制备。用于口服给药的固体制剂中包含片剂、丸剂、散剂、颗粒剂、胶囊剂等，这种固体制剂在一种或以上的化合物中混合至少一种的赋形剂，例如，淀粉、碳酸钙、蔗糖(sucrose)或乳糖(lactose)、明胶等来进行制备。并且，除了单纯的赋形剂之外，还使用硬脂酸镁、滑石等的润滑剂。悬浮液、内用液剂、乳剂、糖浆等属于作为用于口服给药的液体制剂，除了作为通常使用的单纯稀释剂的水、液体石蜡之外，可包含多种赋形剂，例如，润湿剂、甜味剂、芳香剂、防腐剂等。用于非口服给药的制剂中包含已灭菌的水溶液、非水溶剂、悬浮液、乳剂、冷冻干燥制剂、栓剂。
作为非水溶剂、悬浮溶剂可使用丙二醇(propyleneglycol)、聚乙二醇、橄榄油等的植物油、油酸乙酯等的可进行注射的酯等。作为栓剂的基质可使用甘油明胶(witepsol)、聚乙二醇、吐温(tween)61、可可油脂、梓、甘油明胶等。
本发明的组合物的药学上的给药形态能够以上述组合物的药学上允许使用的盐的形态使用，并且不仅能够以单独或与其他药学上的活性化合物相结合的形态来使用，还能够以适当的集合来使用。作为上述盐只要是药学上允许使用的，就不做特别限定，可使用例如，盐酸、硫酸、硝酸、磷酸、氢氟酸、氢溴酸、蚁酸、酒石酸、乳酸、柠檬酸、富马酸、马来酸、琥珀酸、甲磺酸、苯磺酸、甲苯磺酸、萘磺酸等。
本发明的组合物可根据所要达到的目的而进行非口服给药或口服给药，可在一日分1至数次来进行给药，使每1kg的体重以0.1mg至500mg的量进行给药。对于特定患者的给药量可根据患者的体重、年龄、性别、健康状态、膳食、给药时间、给药方法、排泄率、疾病的严重程度等来变化。
本发明的药学组合物分别根据常规的方法，包含散剂、颗粒剂、片剂、胶囊剂、悬浮液、乳剂、糖浆、气雾剂等的口服型剂型、软膏、霜剂等的外用剂、栓剂及灭菌注射用液等的适合于药剂学上的制剂的任意形态，都可进行剂型化来使用。
本发明的组合物可通过非口服、口服等的多种方式对大鼠、小鼠、家畜、人类等的哺乳动物给药，可以预料给药的所有方法，例如，可通过口服、直肠或静脉、肌肉、皮下、子宫内硬膜或脑血管内(intracerebroventricular)注射来进行给药。
另一方面，本发明的组合物因不存在太严重的毒性及副作用，当以预防为目的长时间使用时，也可放心使用。
并且，本发明提供包含昌化鹅耳枥叶提取物作为有效成分的用于促进毛发生长的化妆品组合物。
优选地，上述昌化鹅耳枥叶提取物的浓度为0.001μg/ml至10μg/ml，但不限于此。
优选地，上述组合物为选自由生发水、润发乳、护发精华素、头发洗剂、头发营养水、洗发水、护发素、焗油膏、发乳、营养发乳、头发保湿霜、头发按摩霜、发蜡、头发喷雾剂、发膜、营养发膜、洗发皂、洗发奶、发油、毛发干燥剂、毛发防腐处理剂、染发剂、烫发剂、毛发脱色剂、发胶、毛发釉、美发剂、粘发剂、头发保湿剂、摩丝及定发剂组成的组中的剂型，但不限于此。
上述化妆品组合物可包含脂肪物质、有机溶剂、溶剂、增稠剂、胶凝剂、软化剂、抗氧化剂、悬浮剂、稳定化剂、发泡剂(foaming agent)、芳香剂、表面活性剂、水、离子型或非离子型乳化剂、填充剂、多价螯合剂、螯合剂、防腐剂、维生素、阻隔剂、润湿剂、必要的油、染料、颜料、亲水性或疏水性活化剂、脂质囊泡或化妆品中通常使用的任意其他成分等的化妆品学或皮肤科学领域中通常使用的助剂。上述助剂以化妆品学或皮肤科学领域中通常使用的量来导入。
根据上述的化妆品组合物可以为例如化妆品组合物，化妆品组合物的外形包含化妆品学或皮肤科学上允许使用的介质或基质。这作为适合局部应用的所用剂型，能够以例如，溶液、凝胶、固体、捏合无水生成物、在水相中分散油相所取得的乳胶、悬浮液、微乳剂、微囊剂、细颗粒剂或离子型(脂质体)及非离子型的囊泡分散剂的形态或霜剂、化妆水、乳液、散剂、软膏、喷雾剂或遮瑕棒的形态来提供。这些组合物可根据该领域的常规的方法来制备。本发明的组合物还能够以发泡(foam)的形态或还包含压缩的推进剂的气溶胶组合物的形态来使用。
本发明的化妆品组合物在剂型方面不受特别限制，可剂型化为例如，柔软化妆水、收敛化妆水、营养化妆水、营养霜、按摩霜、精华素、眼霜、眼部精华、洁面乳、洁面泡沫、洁面水、面膜、粉、润肤露、润肤乳、润肤油、美肌精华液等的化妆品。
如上所述的化妆品组合物能够以涂抹于皮肤的形态来利用，还可利用微型针等以向皮肤内部吸收的形态来适用。
并且，本发明的组合物可通过包含适合于涂敷毛发中的载体或载体混合物来制备成毛发组合物。载体包含与溶剂不同的载体或通常用于毛发保护组合物的赋形剂(vehicle)成分，在全部组合物的总重量中以约0.5％至99.5％，优选地，以约5.0％至99.5％，更优选地，以约10.0％至90.0％存在。作为载体，溶剂由共聚物来选择，上述共聚物无关于剂型化的毛发组合物与发胶、摩丝及发根营养液一同使用后残留于毛发或与洗发液、护发素等一同清洗而使用。优选地，在本发明中使用的适当的溶剂包含水、低级醇(乙醇、异丙醇等)、水醇类混合物、烃(异丁烷、己烷、葵烯等)、丙酮、卤代烃(氟利昂等)、烃酯(乙酸乙酯、邻苯二甲酸二丁酯等)、挥发性硅氧烷衍生物、硅氧烷(苯基五甲基二硅氧烷、甲氧基丙基甲基庚环四硅氧烷、氯丙基五甲基二硅氧烷、羟丙基五甲基二硅氧烷、八甲基环四、十甲基环戊硅氧烷等)及它们的混合物。
并且，本发明提供包含昌化鹅耳枥叶提取物作为有效成分的用于防止脱发或促进毛发生长的保健食品。
优选地，上述昌化鹅耳枥叶提取物的浓度为0.001μg/ml至10μg/ml，但不限于此。
优选地，上述保健食品为粉末、颗粒、片剂、胶囊或饮料，但不限于此。
本发明的食品可以按原样添加上述昌化鹅耳枥叶提取物或与其他食品或食品成分一同使用，并且可以根据常规方法适当地使用。
上述食品的种类不受特别限制。可添加上述昌化鹅耳枥叶提取物的食品有例如肉类、香肠、面包、巧克力、糖果类、零食类、饼干类、比萨、拉面、其他面类、口香糖类、包括冰淇淋在内的乳制品、各种汤、饮用水、茶、饮料、酒精饮料及微生物复合剂等，并包括常规意义上的所有食品。
如同普通饮料，本发明的饮料组合物可以包含多种香味剂或天然碳水化合物作为附加成分。上述天然碳水化合物为诸如葡萄糖和果糖之类的单糖、诸如麦芽糖和蔗糖之类的二糖、诸如糊精和环糊精之类的多糖、以及木糖醇、山梨醇和赤藓糖等糖醇。作为甜味剂，可以使用诸如索马甜、甜叶菊提取物之类的天然香味剂或诸如糖精和阿斯巴甜之类的合成香味剂等。上述天然碳水化合物的比例通常为在每100ml的本发明的组合物中约0.01～0.04g，优选约0.02～0.03g。
除上述之外，本发明的食品可以包含多种营养素、维生素、电解质、风味剂、着色剂、果胶及其盐、藻酸及其盐、有机酸、保护性胶体增稠剂、pH调节剂、稳定剂、防腐剂、甘油、醇、碳酸饮料中所使用的碳酸化剂等。另外，可以包含用于制备天然果汁、果汁饮料、及蔬菜饮料的果肉。这种成分可以单独或混合使用。这种添加剂的比例不太重要，但通常在每100重量份的本发明的组合物中包含0.001～0.1重量份的范围内选择。
发明的效果
昌化鹅耳枥叶提取物被认定为通过促进毛发生长中重要的毛乳头细胞的增殖来具有抑制及预防脱发且促进毛发生长的功效，因此可在药学、化妆品及美容等领域中以多种方式应用。
附图说明
图1为确认在不同浓度下昌化鹅耳枥叶提取物的毛乳头细胞(DPCs)增殖促进效果的图。米诺地尔被用作阳性对照组，并且比较了利用昌化鹅耳枥叶提取物(0.01μg/ml、0.1μg/ml及1μg/ml)处理毛乳头细胞的状态。
图2为分离大鼠的生长期触须毛囊(vibrissa follicle)来确认不同浓度下的昌化鹅耳枥叶提取物对毛囊的长度生长产生的影响的图。米诺地尔被用作阳性对照组，并且利用昌化鹅耳枥叶提取物(0.001μg/ml、0.01μg/ml及0.1μg/ml)处理触须毛囊来确认了毛囊的长度生长。
具体实施方式
以下，为了助于理解本发明，例举实施例来进行详细的说明。然而，下述实施例仅为用于例示本发明的内容，本发明的范畴并不由下述实施例而限定。本发明的实施例是为了给本发明所属技术领域中普通技术人员更加完整地说明本发明而提供。
以下所有测量结果以平均±标准偏差或平均±标准误差表示，通过学生t检验(student's t-test)进行统计学显著性检验，当p值(p-value)小于0.05时，认定了显著性。统计处理使用了Sigma Stat统计软件(Sigma Stat software)(Jandel ScientificSoftware，美国)。
实施例1：制备昌化鹅耳枥叶提取物
在从生长在韩国济州岛的昌化鹅耳枥(Carpinus tschonoskiiMaxim.var.tschonoskii)采集的叶子的干燥粉末100g中加入1升(liter)的80％EtOH，并在室温下提取24小时。回收上清液，并使用旋转蒸发器(rotary evaporator)进行减压浓缩之后得到20.8g的80％EtOH提取物。该试样由韩国济州生物种类多样性研究所提供(销售号JBRI-10435)。利用50％EtOH(1：1混合PBS：EtOH)溶解所购买的试样并用于实验中。
实施例2：确认昌化鹅耳枥叶提取物的毛乳头细胞(Dermal papilla cell，DPCs)增殖促进效果
将从白鼠胡须中分离的永生化的毛乳头细胞(Rat vibrissa immortalizeddermal papilla cell：Filsell W，et al.，1994)利用包含100units/ml的青霉素(penicillin)-100μg/ml的链霉素(streptomycin)(Gibco Inc，纽约，美国)和10％的热灭活胎牛血清(heat-inactivated fetal bovine serum)(FBS；Gibco Inc，纽约，美国)的DMEM(Hyclone Inc，美国)培养基，在37℃的温度、5％的CO2恒温仪中进行了培养，并且每3天一次进行了继代培养。利用四唑盐比色法(MTT assay)测量了毛乳头细胞(dermalpapilla cell)的增殖。将1.0×104cells/ml的毛乳头细胞(dermal papilla cell)混合于包含1％的FBS的DMEM培养基中，并放入96孔板中，进行24小时培养之后，将3-溴-4，5-二羟基苯甲醛以0.001μM、0.01μM、0.1μM及1μM的浓度进行了处理。作为阳性对照组的米诺地尔(minoxidil)(西格玛公司，密苏里州，美国)以10μM的浓度进行了处理。培养4天之后，放入50μl的MTT(西格玛公司，密苏里州，美国)，进行了4小时的反应。去除上清液，放入200μl的DMSO使沉淀物溶解时候，利用VERSAmax microplate reader(Molecular Devices公司，加利福尼亚州，美国)，在540nm测量了吸光度。求出各个试样组的平均吸光度的值，与对照组的吸光度值相比较来调查了增殖程度。
通过使用毛乳头细胞(dermal papilla cell)来调查昌化鹅耳枥叶提取物是否具有毛发生长功效的结果，当分别以0.01μg/ml、0.1μg/ml及1μg/ml的浓度处理昌化鹅耳枥叶提取物时，相对于对照组，毛乳头细胞(dermal papilla cell)的增殖分别增加了114.6±10.2％(p＜0.05)、119.9±4.7％(p＜0.001)及105.0±9.4％左右(图1)。尤其，在0.1μg/ml的浓度下，相对于作为阳性对照物质使用的10μM米诺地尔的增殖效果117.4±6.1％(p＜0.01)，昌化鹅耳枥叶提取物呈现出更高的毛乳头细胞增殖功效。该结果表明昌化鹅耳枥叶提取物具有毛发生长功效。
实施例3：确认昌化鹅耳枥叶提取物诱导毛囊生长
从(株)中央实验动物购买出生3个星期的雄性的维斯塔尔大鼠(Wistar rat)(Japan SLC，滨松，日本)，并利用CO2气体进行了安乐死。将大鼠(rat)的左侧和右侧触须垫(mystacial pads)进行分离，放入包含有100units/ml的青霉素(penicillin)-100μg/ml的链霉素(streptomycin)(Gibco Inc，纽约，美国)的E/P缓冲液(E/P buffer)[Earle'sbalanced salts solution(EBSS，西格玛公司，密苏里州，美国)+phosphate-bufferedsaline(PBS，西格玛公司，密苏里州，美国)]。利用解剖显微镜进行观察，小心地对触须毛囊(vibrissa follicles)进行了分离。直到毛囊全部分离，将分离的毛囊放入具有E/P缓冲液的培养皿(Petri dish)中，在37℃的温度、5％的CO2恒温仪中培养了1小时左右。24孔板(well plate)的各个孔中放入包含2mM的L-谷氨酰胺(L-glutamine)(Gibco Inc，纽约，美国)、10μg/ml的胰岛素(insulin)(西格玛公司，密苏里州，美国)、50nM的氢化可的松(hydrocortisone)(西格玛公司，密苏里州，美国)及100units/ml的青霉素(penicillin)-100μg/ml的链霉素(streptomycin)的500μl的William E medium(Gibco Inc，NY，美国)，一个孔(well)中各放入一个毛囊，并在37℃的温度、5％的CO2的恒温仪中进行了培养。培养过程中每3天更换培养基，并且以0.001μg/ml、0.01μg/ml及0.1μg/ml的浓度对昌化鹅耳枥叶提取物进行了处理。将作为阳性对照物质的米诺地尔(minoxidil)以10μM的浓度进行了处理。
培养中的触须毛囊形态利用显微镜(Olympus，日本)进行了拍摄。毛囊长度利用图像分析仪(image analyzer)(DP控制器；Olympus，日本)进行了测量。求出毛囊长度变化的平均值，与对照组的平均长度相比较来测量了生长程度。
对出生3个星期的大鼠的生长期的触须毛囊进行分离，培养3个星期，并测量毛囊长度，从而调查昌化鹅耳枥叶提取物是否具有毛发生长功效。其结果，当在第21天对昌化鹅耳枥叶提取物处理组和对照组之间的毛囊的长度之差(％)进行比较时，在分别以0.01μM、0.1μM及1μM进行处理的情况下，与对照组相比，毛发纤维(hair fiber)的生长分别增加至149.1±14.2％(P＜0.01)、147.9±17.5％(P＜0.05)及142.7±19.9％(图2)。尤其，在0.001及0.01μg/ml的浓度下，昌化鹅耳枥叶提取物的毛发纤维(hair fiber)的生长增加效果高于用作阳性对照物质的米诺地(10μM)的121.9±19.6％生长增加效果。
制剂例1：制备片剂
根据片剂的常规制备方法，将上述多种成分以所提出的含量添加并均匀混合后搅拌，之后颗粒化。干燥后使用压片机制备出了每片含有1mg的昌化鹅耳枥叶提取物作为有效成分的所需的片剂。
制剂例2：制备胶囊剂
根据胶囊剂的常规制备方法，将上述多种成分以所提出的含量添加并均匀混合后，以每个胶囊含有1mg昌化鹅耳枥叶提取物的方式填充于适当大小的明胶胶囊中，从而制备出了所需的胶囊剂。
制剂例3：皮肤外用剂中的软膏
根据软膏的常规制备方法，通过以所提出的含量添加上述多种成分并均匀混合来制备出了软膏。
制剂例4：制备散剂
根据散剂的常规制备方法，通过混合上述多种成分并填充于气密布来制备出了散剂。
制剂例5：制备液剂
根据液剂的常规制备方法，通过混合上述多种成分来制备出了液剂。
制剂例6：制备生发水
根据生发水的常规制备方法，通过混合上述多种成分来制备生发水。
制剂例7：制备润发乳
根据润发乳的常规制备方法，通过混合上述多种成分来制备润发乳。
制剂例8：柔软化妆水(润肤液)
表1
| 配合成分 | 含量(重量百分比) |
| 昌化鹅耳枥叶提取物 | 0.1 |
| 甘油 | 3.0 |
| 丁二醇 | 3.0 |
| 丙二醇 | 3.0 |
| 羧基乙烯聚合物 | 0.1 |
| 蜂蜡 | 4.0 |
| 聚山梨酯60 | 1.5 |
| 辛酸/癸酸甘油三酯 | 5.0 |
| 角鲨烷 | 5.0 |
| 花生四烯酸 | 1.5 |
| 液体石蜡 | 0.5 |
| 鲸蜡硬脂醇 | 1.0 |
| 三乙醇胺 | 0.2 |
| 防腐剂、色素及香料 | 适量 |
| 纯化水 | 剩余量(至100) |
根据上表1中所记载的组成来以常规方法制备出了柔软化妆水。
制剂例9：营养霜
表2
根据上表2中所记载的组成来以常规方法制备出了营养霜。
制剂例10：面膜
表3
根据上表3中所记载的组成来以常规方法制备出了面膜。
Claims (9)
1.一种用于防止脱发的药学组合物，其特征在于，包含昌化鹅耳枥叶提取物作为有效成分。
2.根据权利要求1所述的用于防止脱发的药学组合物，其特征在于，上述昌化鹅耳枥叶提取物的浓度为0.001μg/ml至10μg/ml。
3.根据权利要求1所述的用于防止脱发的药学组合物，其特征在于，上述用于防止脱发的药学组合物为选自由片剂、胶囊剂、注射剂、霜剂、凝胶剂、贴剂、喷雾剂、软膏剂、硬膏剂、洗剂、擦剂、糊剂及泥敷剂组成的组中的剂型。
4.一种用于防止脱发或促进毛发生长的化妆品组合物，其特征在于，包含昌化鹅耳枥叶提取物作为有效成分。
5.根据权利要求4所述的用于防止脱发或促进毛发生长的化妆品组合物，其特征在于，上述昌化鹅耳枥叶提取物的浓度为0.001μg/ml至10μg/ml。
6.根据权利要求4所述的用于防止脱发或促进毛发生长的化妆品组合物，其特征在于，上述用于防止脱发或促进毛发生长的化妆品组合物为选自由生发水、润发乳、护发精华素、头发洗剂、头发营养水、洗发水、护发素、焗油膏、发乳、营养发乳、头发保湿霜、头发按摩霜、发蜡、头发喷雾剂、发膜、营养发膜、洗发皂、洗发奶、发油、毛发干燥剂、毛发防腐处理剂、染发剂、烫发剂、毛发脱色剂、发胶、毛发釉、美发剂、粘发剂、头发保湿剂、摩丝及定发剂组成的组中的剂型。
7.一种用于防止脱发或促进毛发生长的保健食品，其特征在于，包含昌化鹅耳枥叶提取物作为有效成分。
8.根据权利要求7所述的用于防止脱发或促进毛发生长的保健食品，其特征在于，上述昌化鹅耳枥叶提取物的浓度为0.001μg/ml至10μg/ml。
9.根据权利要求7所述的用于防止脱发或促进毛发生长的保健食品，其特征在于，上述用于防止脱发或促进毛发生长的保健食品为粉末、颗粒、片剂、胶囊或饮料。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170121111A KR101918656B1 (ko) | 2017-09-20 | 2017-09-20 | 개서어나무 잎 추출물을 포함하는 탈모 방지 또는 육모 촉진을 위한 조성물 |
| KR10-2017-0121111 | 2017-09-20 | ||
| PCT/KR2018/004543 WO2019059484A1 (ko) | 2017-09-20 | 2018-04-19 | 개서어나무 잎 추출물을 포함하는 탈모 방지 또는 육모 촉진을 위한 조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111107861A true CN111107861A (zh) | 2020-05-05 |
| CN111107861B CN111107861B (zh) | 2022-05-24 |
Family
ID=64363477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201880061001.3A Active CN111107861B (zh) | 2017-09-20 | 2018-04-19 | 昌化鹅耳枥叶的乙醇提取物在制备用于防止脱发的药学组合物中的用途 |
Country Status (3)
| Country | Link |
|---|---|
| KR (1) | KR101918656B1 (zh) |
| CN (1) | CN111107861B (zh) |
| WO (1) | WO2019059484A1 (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080009845A (ko) * | 2006-07-25 | 2008-01-30 | 코스맥스 주식회사 | 세포 보호 작용을 갖는 개서어나무 추출물 |
| CN104188833A (zh) * | 2009-02-05 | 2014-12-10 | 罗地亚管理公司 | 适合作为洗发剂的水性组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005281174A (ja) * | 2004-03-29 | 2005-10-13 | Sanei Seiyaku Kk | 活性酸素消去剤 |
| JP3830960B1 (ja) * | 2005-08-12 | 2006-10-11 | 建仁 河乃 | 育毛物質 |
| KR100866784B1 (ko) | 2007-05-11 | 2008-11-04 | 코스맥스 주식회사 | 개서어나무 잎 추출물을 포함하는 피부주름 개선용 화장료조성물 |
| KR20090111991A (ko) * | 2008-04-23 | 2009-10-28 | 코스맥스 주식회사 | 항염 효과를 갖는 개서어나무 추출물을 함유하는 화장료조성물 |
-
2017
- 2017-09-20 KR KR1020170121111A patent/KR101918656B1/ko active IP Right Grant
-
2018
- 2018-04-19 CN CN201880061001.3A patent/CN111107861B/zh active Active
- 2018-04-19 WO PCT/KR2018/004543 patent/WO2019059484A1/ko active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080009845A (ko) * | 2006-07-25 | 2008-01-30 | 코스맥스 주식회사 | 세포 보호 작용을 갖는 개서어나무 추출물 |
| CN104188833A (zh) * | 2009-02-05 | 2014-12-10 | 罗地亚管理公司 | 适合作为洗发剂的水性组合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111107861B (zh) | 2022-05-24 |
| WO2019059484A1 (ko) | 2019-03-28 |
| KR101918656B1 (ko) | 2018-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101651833B1 (ko) | 감귤류 과피 추출물을 포함하는 탈모 방지 또는 발모 촉진용 조성물 | |
| KR102112736B1 (ko) | 탈모 방지 또는 발모 촉진용 조성물 | |
| KR101889793B1 (ko) | 수산동물 발효물을 포함하는 탈모 방지 및 육모 촉진을 위한 조성물 | |
| KR20160059271A (ko) | 파시플로라 에듈리스의 꽃 추출물을 포함하는 두피 상태 개선용 조성물 | |
| EP3205345A1 (en) | Composition for hair loss prevention or hair growth stimulation comprising artemisia umbelliformis extract | |
| KR101541470B1 (ko) | 진세노사이드 ｆ2를 포함하는 탈모방지 또는 발모촉진용 조성물 | |
| KR102591604B1 (ko) | 코나루스 세미데칸드러스 잭. 추출물을 포함하는 탈모 예방 또는 치료용 약학적 조성물 | |
| CN111107861B (zh) | 昌化鹅耳枥叶的乙醇提取物在制备用于防止脱发的药学组合物中的用途 | |
| KR102079977B1 (ko) | 휴매닌(Humanin)을 포함하는 탈모 방지 또는 육모 촉진을 위한 조성물 | |
| KR101529380B1 (ko) | 적하수오에서 분리한 화합물을 포함하는 탈모 방지 또는 육모 촉진을 위한 조성물 | |
| KR101510939B1 (ko) | 밀기울 추출물을 유효성분으로 포함하는 탈모 방지 또는 육모 촉진 조성물 | |
| KR101829514B1 (ko) | 줄의관말 추출물을 포함하는 탈모 방지 또는 육모 촉진을 위한 조성물 | |
| KR101609436B1 (ko) | 갈고리가시우무 추출물을 포함하는 탈모 방지 또는 육모 촉진을 위한 조성물 | |
| KR20210025155A (ko) | 수벌번데기 추출물을 포함하는 탈모방지 또는 육모촉진용 조성물 | |
| KR20150144688A (ko) | 파시플로라 인카르나타(Passiflora incarnate) 추출물을 포함하는 두피 상태 개선용 조성물 | |
| CN106572983B (zh) | 包含3-溴-4，5-二羟基苯甲醛化合物作为有效成分防止脱发或毛发生长促进用组合物 | |
| KR101609437B1 (ko) | 갈고리참곱슬이 추출물을 포함하는 탈모 방지 또는 육모 촉진을 위한 조성물 | |
| KR101420913B1 (ko) | 넓미역 추출물 함유 탈모방지 또는 발모개선용 조성물 | |
| KR101469662B1 (ko) | 비틀대모자반 추출물 함유 탈모방지 또는 발모개선용 조성물 | |
| EP3895687A1 (en) | Composition comprising allulose as active ingredient for skin whitening | |
| KR20230071880A (ko) | 탐빛1호 과피 추출물을 포함하는 탈모 증상의 예방, 개선 또는 치료를 위한 조성물 | |
| KR20160059273A (ko) | 파시플로라 콰드랭귤라리스의 꽃 추출물을 포함하는 두피 상태 개선용 조성물 | |
| KR20230071879A (ko) | 미니향 과피 추출물을 포함하는 탈모 증상의 예방, 개선 또는 치료를 위한 조성물 | |
| KR20160059272A (ko) | 파시플로라 라우리폴리아의 꽃 추출물을 포함하는 두피 상태 개선용 조성물 | |
| KR20140016056A (ko) | 가는개도박 추출물 함유 탈모방지 또는 발모개선용 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |